GUARINO, MARIA
 Distribuzione geografica
Continente #
AS - Asia 1.728
EU - Europa 1.097
NA - Nord America 856
SA - Sud America 283
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.017
Nazione #
SG - Singapore 888
US - Stati Uniti d'America 814
RU - Federazione Russa 626
CN - Cina 447
BR - Brasile 234
IT - Italia 152
VN - Vietnam 135
HK - Hong Kong 106
DE - Germania 90
NL - Olanda 63
GB - Regno Unito 47
IN - India 47
KR - Corea 40
FR - Francia 24
AR - Argentina 21
CI - Costa d'Avorio 21
FI - Finlandia 21
CA - Canada 19
MX - Messico 16
JP - Giappone 15
ZA - Sudafrica 12
AT - Austria 11
ID - Indonesia 11
PL - Polonia 11
UA - Ucraina 11
LT - Lituania 10
ES - Italia 9
IE - Irlanda 7
CL - Cile 6
IQ - Iraq 6
JO - Giordania 6
EC - Ecuador 5
SE - Svezia 5
TR - Turchia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
KE - Kenya 4
MA - Marocco 4
NP - Nepal 4
PE - Perù 4
BD - Bangladesh 3
BE - Belgio 3
EG - Egitto 3
PK - Pakistan 3
PY - Paraguay 3
AZ - Azerbaigian 2
HN - Honduras 2
ML - Mali 2
SA - Arabia Saudita 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
ME - Montenegro 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.017
Città #
Singapore 479
Hefei 210
Moscow 151
Hong Kong 105
Beijing 98
Ashburn 88
Santa Clara 88
Chandler 65
Amsterdam 47
Ho Chi Minh City 47
Seoul 38
Kochi 29
Hanoi 27
Naples 25
Los Angeles 23
Buffalo 21
Millbury 21
New York 21
São Paulo 21
Redondo Beach 19
Frankfurt am Main 17
Munich 17
Chicago 16
London 15
Tokyo 15
Council Bluffs 14
Dallas 14
Düsseldorf 12
Falkenstein 12
Helsinki 12
Des Moines 11
Dearborn 10
Warsaw 10
Lawrence 9
Rio de Janeiro 9
Haiphong 8
Manchester 8
Nanjing 8
Toronto 8
Dublin 7
Houston 7
Johannesburg 7
Lauterbourg 7
Mexico City 7
Napoli 7
Nuremberg 7
The Dalles 7
Turin 7
Turku 7
Biên Hòa 6
Boston 6
Denver 6
Joinville 6
Milan 6
Montreal 6
Orem 6
Poplar 6
Princeton 6
Amman 5
Brooklyn 5
Caivano 5
Rome 5
San Francisco 5
Seattle 5
Stockholm 5
Vienna 5
Wilmington 5
Afragola 4
Baghdad 4
Brasília 4
Chennai 4
Da Nang 4
Kronberg 4
Osasco 4
Portsmouth 4
Santa Maria La Carità 4
Ankara 3
Aversa 3
Baronissi 3
Belém 3
Bengaluru 3
Brussels 3
Can Tho 3
Canoas 3
Fortaleza 3
Guayaquil 3
Jacksonville 3
Jundiaí 3
Legnaro 3
Lima 3
Limeira 3
Mumbai 3
Nairobi 3
Ninh Bình 3
Ourinhos 3
Porto Alegre 3
Ribeirão Preto 3
Rochdale 3
Salt Lake City 3
Salvador 3
Totale 2.125
Nome #
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 125
Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection 124
Use of Telemedicine for chronic liver disease at a single care center during the COVID-19 pandemic: Prospective observational study 117
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 114
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 112
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 112
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 111
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 110
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 110
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 104
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 104
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 104
Pattern of macrovascular invasion in hepatocellular carcinoma 103
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination 102
Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients 102
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 102
Metabolic disorders across hepatocellular carcinoma in Italy 99
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 99
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 97
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients 97
The interpretation of liver function tests in pregnancy 92
Corrigendum to "Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV" [J Hepatol 68 (2018) 33-41] 90
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study 90
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 89
Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study 88
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study 87
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma 86
Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease 85
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 85
COVID-19 and Fatty Liver Disorders 84
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 82
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 82
Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy 80
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 77
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 75
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis 74
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 74
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib 74
Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions 66
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 62
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature 59
Tislelizumab: a promising alternative first-line systemic therapy in unresectable advanced hepatocellular carcinoma 57
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open! 53
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice 50
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 47
Vascular liver diseases: A sex-oriented analysis of the literature 45
Totale 4.081
Categoria #
all - tutte 12.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 9 16 0 2 0 1 1
2021/202298 0 0 0 0 1 1 0 4 0 14 40 38
2022/2023200 15 4 3 6 34 23 3 11 24 51 23 3
2023/2024246 6 75 41 20 5 13 2 29 1 13 28 13
2024/20251.497 71 70 0 24 41 104 148 124 90 135 576 114
2025/20261.940 273 359 374 327 510 97 0 0 0 0 0 0
Totale 4.081